AI-generated summary
The authors ran a randomized, observer-blinded multicentre trial of low-level laser therapy added to standard care for stage III decubitus ulcers in 86 patients. They found no significant difference between groups in wound size reduction, and no difference in progression to stage IV ulcers. The authors conclude there is no evidence to justify using the therapy as an adjunct to standard treatment.
- Participants
- 86
- Who or what was studied
- Patients with stage III decubitus ulcers
- Limits stated in the abstract
- The abstract does not state the laser wavelength, and wound size data were non-normally distributed, requiring transformation and other analyses.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Primary outcome, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.